340B Guidance Riles Hospitals, Drug Makers: They Push in Opposite Ways on Eligibility, Discounts, and More

Benzer Materyaller

• Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2013)
• FDA Pushes Plans for Drug Compounding: More Scrutiny for Hospital Pharmacies
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2013)
• Congress Likely to Rein In 340B Drug Discount Program: The HRSA’s Draft Guidance and a Proposed Rule Give Legislators an Opening
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2015)
• The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2016)
• Health Care Reform Bill Expands Access to Section 340B Discounted Drugs for Hospitals
  Yazar:: Barlas, Stephen
  Baskı/Yayın Bilgisi: (2010)